Prostate Health Month 2025: Prostatitis, Cancer, and BPH
Clinical insights into prostatitis, prostate cancer, and benign prostatic hyperplasia: epidemiology, risk factors, and evidence-based management.
Medical Affairs
3 min read
September 16, 2025
Carregando conteúdo…
Oncology
Highlights
TribeMD
ASCO GU® 2026
Medical Affairs
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer
TribeMD
SnackableHealth™ | From Intervention to Prevention: How Secondary Prevention Clinics Are Redefining Post-ACS Care
TribeMD
ASCO GU® 2026
Medical Affairs
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer
TribeMD
SnackableHealth™ | From Intervention to Prevention: How Secondary Prevention Clinics Are Redefining Post-ACS Care